Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents

Robert L. Findling

Research output: Contribution to journalReview articlepeer-review

Abstract

Disruptive behavior disorders, including conduct disorder, oppositional defiant disorder, and disruptive behavior disorder not otherwise specified, are serious conditions in children and adolescents that include a behavior pattern of violating the basic rights of others and age-appropriate rules or standards and may include aggressive behavior. Although no pharmacotherapy is currently approved for use in this population, evidence suggests that atypical antipsychotic treatment may be useful in patients with these conditions who present with problematic aggression. Currently, research on risperidone shows it to be effective in treating aggressive behavior in this patient population. Limited research is also available on olanzapine, quetiapine, and aripiprazole, but more research is needed on these and other agents. As with any pharmacotherapy, adverse events (including weight gain, headache, and somnolence) should be carefully considered with these medications, especially in children and adolescents, and it is important to properly dose and monitor patients during medication therapy.

Original languageEnglish (US)
Pages (from-to)9-14
Number of pages6
JournalJournal of Clinical Psychiatry
Volume69
Issue numberSUPPL. 4
StatePublished - Dec 1 2008
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents'. Together they form a unique fingerprint.

Cite this